TrialGut and liver2023

Efficacy and Safety of Infliximab in Intestinal Behçet's Disease: A Multicenter, Phase 3 Study (BEGIN).

Jae Hee Cheon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.